CClinicalTrials.gg
Not yet recruitingNCT06142045Updated Mar 6, 2024

Brain Blood Flow Responses at Rest and During Exercise

An observational study in Cerebrovascular Regulation, sponsored by University of British Columbia. Not yet recruiting. Open to participants aged 7 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-03-06.

Sponsored by University of British Columbia · Observational

From the registry’s dates

  • Primary completion was expected by Jan 2025, 1 year 9 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
60
Ages
7 Years to 35 Years
Sex
All
01

Study summary

Tight regulation of brain blood flow is integral for delivery of oxygen and energy for survival. During childhood, the brain has a twofold higher metabolic requirement, thus requires greater blood flow to match this. Despite this knowledge, brain blood flow responses and the mechanisms of regulation during maturation are largely unknown. Thus, we are trying to understand what happens to blood vessel function and the mechanisms of regulation at rest and during handgrip exercise. This will give us valuable information on brain blood vessel responses, which will help future interventions aimed at improving blood vessel function in youth, for future disease prevention. Utilizing the pubertal transition will provide insights into the influence of sex hormones on brain blood flow regulation.

The goal of this cross-sectional observational study is to examine the influence of age and maturation on cerebral blood flow regulation, achieved through exploring the responses to increases in carbon dioxide concentrations, and static handgrip exercise in children (7-10 years), adolescents (12-16 years) and young adults (19-35 years).

The main questions the study aims to answer are:

  • Investigate the brain blood flow responses to increases in carbon dioxide concentrations in children, adolescents and adults.
  • Investigate brain blood flow responses to handgrip exercise with and without increases in carbon dioxide concentrations in children, adolescents and adults.

During all protocols, participants will have their end-tidal gas concentrations measured and/or altered using prospective end-tidal gas targeting using a computer controlled gas blender system in which we have obtained Health Canada approval for.

Read the detailed description

The goal of this cross-sectional experimental study to determine the influence age, sex and pubertal status on cerebrovascular responses at rest and during isometric exercise.

The main objective is to investigate the regulatory mechanisms of cerebral blood flow during hypercapnia and isometric exercise, and determine whether any mechanistic differences in regulation are present with advancing age and maturation.

The following questions will be addressed in 20 healthy children (7-10 years), 20 healthy adolescents (12-16 years) and 20 young healthy adults (19-35 years), to compare the influence of age, sex and maturation on these responses, as follows:

  1. Investigate the brain blood flow responses to isometric exercise with and without hypercapnia (+9 mmHg carbon dioxide) in children, adolescents and adults.
  2. Investigate the brain blood flow responses to hypercapnia (+9 mmHg carbon dioxide) in children, adolescents and adults using a ramp incremental 4 minute protocol compared with a 30 second protocol, to identify which method is the most tolerable in children and adolescents.
  3. Determine whether sex, and the sex-dependent influences of age and maturation influence any of the brain blood flow responses to hypercapnia or isometric handgrip exercise.

To control and manipulate breathing gases during the study protocols, the partial pressures of end-tidal carbon dioxide and oxygen will be sampled at the mouth using the Investigational Testing Authorization approved computer controlled gas blender system. To target specific end-tidal carbon dioxide and oxygen levels during the clamped breathing and hypercapnic trials respectively, prospective end-tidal gas targeting will be utilized. The system allows for breath-by-breath regulation of end-tidal gases, independently of ventilation. End-tidal concentrations are prospectively targeted by controlling the inspired concentration of carbon dioxide and oxygen according to the previous expired breath, allowing this to be precisely controlled throughout the duration of the protocol. Gas analysis, and spirometry measures of tidal volume and breathing frequency will be recorded using the computer controlled system. Prospective end-tidal gas targeting is safe, with all inspired gases containing oxygen, with rigorous control procedures and fail-safe mechanisms which do not allow inhaled gases to fall outside of safe thresholds.

02

Conditions studied

  • Cerebrovascular Regulation
03

In context

Lead sponsor

University of British Columbia is the lead sponsor of 1,309 studies on the registry; 253 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 1 (17%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

The study population will be healthy children, adolescents and adults between the ages of 7-10 years, 12-16 years or 19-35 years of age. Participants will be recruited from the general population from online advertisements and media, targeting children, adolescents and adults residing in the Okanagan, British Columbia.

Inclusion criteria

  • Are aged between 7-10 years, 12-16 years or 19-35 years
  • Male or Female
  • Have a normal blood pressure (\<160/110 mmHg) and are not taking any anti-hypertensive medications.
  • No prior or current history of cardiorespiratory of cerebrovascular diseases.
  • Can communicate in English

Exclusion criteria

Exclusion Criteria:

  • Inability to perform handgrip exercise
  • Are currently taking any medications known to influence vascular function, heart rate or blood pressure
  • Have epilepsy
  • Are a current smoker
  • Have known cardiometabolic abnormalities
  • Have congenital cardiac abnormalities (e.g., tetralogy of Fallot)
  • Unstable angina (frequent chest pain)
  • Atrial Fibrillation
  • Myocardial infarction (heart attack) within the previous 3 months
  • Transient ischemic attack (TIA) within the previous 6 months
  • Heart failure ≥ class 2
  • Have a known respiratory disease (e.g., asthma)
  • Have a known metabolic disease (e.g., Type 1 diabetes)
  • Are unable to exercise
  • Are pregnant
  • Less than 6 months post childbirth or stopped breastfeeding within the last month
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
60 participants (estimated)
Patient registry
No

Groups and cohorts

  • Children (7-10 years)

    All groups of the experiment will be exposed to the same intervention. The intervention the participants are exposed to is the use of the computer controlled gas blender system for manipulation of end-tidal and arterial blood gases. This will be used for the following protocols, to either clamp end-tidal concentrations at resting levels or administer a hypercapnia challenge. The protocol includes assessment of cerebral blood flow responses (measured using ultrasound) to carbon dioxide; including a hypercapnia ramp protocol followed by a transient protocol. Following at least 30 minute wash out, participants will then perform isometric exercise at 30% of their maximal voluntary contraction for 2 minutes. Participants will perform the isometric handgrip exercise under 2 different conditions (hypercapnia (+9 mmHg) and clamped breathing; to maintain baseline end-tidal carbon dioxide and oxygen concentrations) with a 20-minute recovery period between each bout.

    Device: RespirACT RA-MR System

  • Adolescents (12-16 years)

    All groups of the experiment will be exposed to the same intervention. The intervention the participants are exposed to is the use of the computer controlled gas blender system for manipulation of end-tidal and arterial blood gases. This will be used for the following protocols, to either clamp end-tidal at resting levels or administer a hypercapnia challenge. The protocol includes assessment of cerebral blood flow responses (measured using ultrasound) to carbon dioxide; including a hypercapnia ramp protocol followed by a transient protocol. Following at least 30 minute wash out, participants will then perform isometric exercise at 30% of their maximal voluntary contraction for 2 minutes. Participants will perform the isometric handgrip exercise under 2 different conditions (hypercapnia (+9 mmHg) and clamped breathing; to maintain baseline end-tidal carbon dioxide and oxygen concentrations) with a 20-minute recovery period between each bout.

    Device: RespirACT RA-MR System

  • Adults (18-35 years)

    All groups of the experiment will be exposed to the same intervention. The intervention the participants are exposed to is the use of the computer controlled gas blender system for manipulation of end-tidal and arterial blood gases. This will be used for the following protocols, to either clamp end-tidal at resting levels or administer a hypercapnia challenge. The protocol includes assessment of cerebral blood flow responses (measured using ultrasound) to carbon dioxide; including a hypercapnia ramp protocol followed by a transient protocol. Following at least 30 minute wash out, participants will then perform isometric exercise at 30% of their maximal voluntary contraction for 2 minutes. Participants will perform the isometric handgrip exercise under 2 different conditions (hypercapnia (+9 mmHg) and clamped breathing; to maintain baseline end-tidal carbon dioxide and oxygen concentrations) with a 20-minute recovery period between each bout.

    Device: RespirACT RA-MR System

Interventions

  • DeviceRespirACT RA-MR System

    RespirAct RA-MR™ is a computer-controlled gas blender to implement precise control of blood gases for a consistent and repeatable stimulus.

06

What researchers measure

Primary outcomes

  1. Cerebral blood flow

    Ultrasound assessment of the internal carotid artery blood flow

    Time frame: Experimental visit (1 day)

Secondary outcomes

  1. Cerebral blood velocity

    Ultrasound assessment of the middle cerebral artery velocity

    Time frame: Experimental visit (1 day)

  2. Beat-by-beat blood pressure

    Continuous assessment of mean arterial pressure responses

    Time frame: Experimental visit (1 day)

  3. Saliva hormone concentrations

    Saliva specimen samples for the assessment of estrogen, progesterone, dehydroepiandrosterone and testosterone for the characterization of maturation status

    Time frame: Experimental visit (1 day)

  4. Physical activity questionnaire

    Self report assessments of physical activity levels will be assessed

    Time frame: Experimental visit (1 day)

  5. Anthropometrics: weight

    Body mass (kg) will be measured with electronic scales

    Time frame: Experimental visit (1 day)

  6. Gas analysis

    The partial pressures of end-tidal carbon dioxide and oxygen will be sampled at the mouth from a fitted respiratory face mask.

    Time frame: Experimental visit (1 day)

  7. Anthropometrics: height

    Stature standing and sitting height will be measured (cm).

    Time frame: Experimental visit (1 day)

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Ito S, Mardimae A, Han J, Duffin J, Wells G, Fedorko L, Minkovich L, Katznelson R, Meineri M, Arenovich T, Kessler C, Fisher JA. Non-invasive prospective targeting of arterial P(CO2) in subjects at rest. J Physiol. 2008 Aug 1;586(15):3675-82. doi: 10.1113/jphysiol.2008.154716. Epub 2008 Jun 19. PubMed 18565992 ↗
  • Fisher JA. The CO2 stimulus for cerebrovascular reactivity: Fixing inspired concentrations vs. targeting end-tidal partial pressures. J Cereb Blood Flow Metab. 2016 Jun;36(6):1004-11. doi: 10.1177/0271678X16639326. Epub 2016 Mar 21. PubMed 27000209 ↗

Individual participant data

Plan to share: Yes — Pseudonymized data from this study will be made available for sharing with other investigators, after publication of the study's key papers. Data will be shared through the Federated Research Data Repository (FRDR) (https://www.frdr-dfdr.ca/repo/). This is a secure data repository, which is searchable on the www, it is managed by Library Services. A digital object identifier (DOI) will be generated for datasets as they are deposited to the repository. Data will be stored in this repository for a minimum of 10 years or for 10 years from the last date of access.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 6, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06142045
Lead sponsor
University of British Columbia
Responsible party
Ai McManus (Professor, University of British Columbia) — Principal investigator
First posted
Nov 21, 2023
Start date
May 1, 2024 (estimated)
Primary completion
Jan 1, 2025 (estimated)
Completion
Jan 1, 2025 (estimated)
Last update
Mar 6, 2024

Study contacts

Ali McManus, PhD
Contact
ali.mcmanus@ubc.ca
250-807-9873
Jodie Koep, PhD
Contact
jodie.koep@ubc.ca
2508631621
Jared Baylis, MD
principal investigator · University of British Columbia

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Mar 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion